The impact of a supplementary medication review and counselling service within the oncology outpatient setting

British Journal of Cancer

Volumn 96, Issue 5, 2007, Pages 744-751

  Read, H ^a   Ladds, S ^a   Rhodes, B ^a   Brown, D ^b   Portlock, J ^b  

^a UK   (United Kingdom)

^b UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Breast cancer; Controlled trial; Medication review; Pharmacy; Technician

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; NAVELBINE; PACLITAXEL; TRASTUZUMAB;

ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; HUMAN; MAJOR CLINICAL STUDY; ONCOLOGY; OUTPATIENT CARE; PATIENT COUNSELING; PHARMACY TECHNICIAN; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

AMBULATORY CARE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COUNSELING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HUMANS; OUTPATIENT CLINICS, HOSPITAL; PATIENT EDUCATION; PHARMACISTS' AIDES; REFERRAL AND CONSULTATION; TIME FACTORS;

EID: 33847700120     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603634     Document Type: Article

References (16)

1. Atkins L, Fallowfield L (2006) Intentional and non-intentional adherence to medication amongst breast cancer patients. Eur J Cancer 42(14): 2271-2276
2. Austwick EA, Brown LC, Goodyear KH (2002) Pharmacists' input into a palliative care clinic. Pharm J 268: 404-406
3. Blenkinsopp A (2001) From compliance to concordance: how are we doing? Int J Pharm Prac 9: 65-66
4. Boddy C (2001) Pharmacist involvement with warfarin dosing for inpatients. Pharm World Sci 23(1): 31-35
5. Craig JB, Powell BL (1987) The management of nausea and vomiting in clinical oncology. Am J Med Sci 293(1): 34-44
6. Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC (2006) Frequency and cost of chemotherapy-related serious adverse events in a population sample of women with breast cancer. J Natl Cancer Inst 98: 1108-1117
7. Horne R (1998a) Representations of medication and treatment: advances in theory and measurement. In Perceptions of Health and Illness Petrie KJ, Weinman JA (eds) pp 155-188. London: Harwood Academic Publishers
8. Horne R (1998b) Adherence to medication - a review of existing research. In Adherence to Treatment in Medical Conditions Myers LB, Midence K (eds) pp 285-310. London: Harwood Academic Publishers
9. Horne R (2000) Nonadherence to medication: causes and implications for care. In Gard P (ed) A behavioural approach to pharmacy practice pp 111-130. London: Blackwell Science
10. Morlidge C (2001) Pharmacist-run renal medication review clinics. Br J Renal Med 3: 25-26
11. Porzsolt F, Meuret G, Kreuser ED, Mende S, Buchelt L, Strigl P, Redenbacher M, Klumpp F, Schmelz M, Knochelmann R (1989) Compliance of physicians and patients with a consensus protocol for treatment of advanced breast cancer. J Cancer Res Clin Oncol 115(6): 564-570
12. Radley AS, Hall J (1994) The establishment of a pharmacist developed anticoagulation clinic. Pharm J 252: 91-92
13. Spiegel D (1997) Psychosocial aspects of breast cancer treatment. Semin Oncol 24: S136-S147
14. Stevenson FA (2001) Concordance: what is the relevance for pharmacists? Int J Pharm Prac 9: 67-70
15. Stevenson FA, Barry CA, Britten N, Barber N, Bradley CP (2000) Doctor-patient communication about drugs: the evidence for shared decision making. Social Sci Med 50: 829-840
16. Tucker R (2004) Pharmacist-led dermatology clinics can improve prisoners' quality of life. Pharm J 272: 577-579